Postoperative pharmacokinetics of meloxicam in horses after surgery for colic syndrome.

This study investigates the behavior of the drug meloxicam in horses following surgery for colic syndrome. The research discovered that the drug’s performance is similar in both healthy and unwell horses, implying that no dose adjustments are needed when used postoperatively.

Introduction

• The study focuses on the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), specifically meloxicam, in horses that have undergone surgery due to colic syndrome.
• NSAIDs are commonly used in such scenarios for their ability to counter endotoxemia and provide analgesic and anti-inflammatory effects.
• The researchers aim to understand the pharmacokinetics (how the body affects a drug) of meloxicam in unwell horses and to test whether the established dosage for healthy horses still holds true in these circumstances.

Methodology

• A total of eight horses were involved in the study. Each horse, nearing the end of their surgery, received a dose of 0.6 mg/kg of meloxicam intravenously (i.v.).
• Over the following 24 hours, researchers collected blood samples from the horses at scheduled intervals to monitor the serum concentration of the drug.
• The High-Performance Liquid Chromatography (HPLC) technique was employed to determine the serum concentration of meloxicam.

Results

• The terminal half-life (6.88 ± 2.96 hours), volume of distribution at steady-state (186.53 ± 61.20 ml/kg), and clearance (27.91 ± 5.72 ml kg hr) matched previously reported values for healthy horses.
• This consistency in data indicates that the pharmacokinetic behavior of meloxicam in unwell horses facing postoperative period due to colic syndrome is in line with that of healthy horses.

Conclusion

• The study suggests no need for dose adjustments when using meloxicam for horses in the immediate postoperative phase after surgery for colic syndrome.
• This can be attributed to the similar drug interaction profile in healthy and unwell horses, thereby providing valuable insights for veterinarians and pharmaceutical companies regarding dosage prescriptions.